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CASE REPORT
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Rothmund–Thomson syndrome (RTS) or poikiloderma congenitale is a rare autosomal recessive disorder. Approximately 300 
cases of this syndrome have been reported in the scientific literature worldwide. This study reports the case of an 11-year-
old female child with RTS undergoing diagnostic oesophago-gastro-duodeno (OGD) scopy as a result of dysphagia to solids. 
Adequate knowledge of the condition is needed when planning anaesthesia in such a case as associated anomalies can interfere 
with anaesthesia management.
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Introduction
Rothmund–Thomson syndrome (RTS) or poikiloderma congenitale 
is attributed to mutations of the RECQL4 helicase gene on 8q24.1 
Approximately 300 cases of this syndrome have been reported in 
scientific literature worldwide.2 Characteristic features include 
photosensitivity, poikilodermatous skin changes, juvenile 
cataracts, skeletal dysplasias, and haematological, gastrointestinal 
and genitourinary abnormalities (Figure 1). Patients also have 
increased likelihood of osteosarcoma and skin cancer.3
We successfully managed a known case of RTS undergoing 
oesophago-gastro-duodeno (OGD) scopy under general 
anaesthesia.
Case study
An 11-year-old child weighing 25  kg was admitted for OGD 
scopy. The patient was a known case of RTS diagnosed at one 
year of age. The patient gave a history of dysphagia to solids for 
the past two months. A history of prolonged bleeding from 
hypertrophic gums was present. A haematology opinion was 
sought to rule out any bleeding disorders. Her vitals were pulse 
rate 110/minute and blood pressure 100/60 mmHg. On physical 
examination hypopigmented and hyperpigmented skin patches 
were present. Examination of the oral cavity revealed gum 
hypertrophy and hypodontia. Airway examination did not reveal 
any other abnormality. The patient had short stature, measuring 
115 cm, which is less than the second centile for her age. Eye 
examination showed the presence of telangiectasia. Systemic 
examination was unremarkable. Laboratory investigations 
including a haemogram, complete blood count, renal function 
tests and coagulation profile were within normal limits. Barium 
swallow revealed an upper oesophageal web with achalasia 
cardia. The patient was listed for OGD scopy.
Standard monitoring included electrocardiography, pulse 
oximetry, and non-invasive blood pressure and temperature 
monitoring. A 24G intravenous cannula was inserted and secured 
using non-adhesive dressing to prevent damage to the fragile 
skin. Injection of midazolam 0.05 mg/kg and injection of fentanyl 
2 ug/kg were given for sedation. Diagnostic OGD scopy was 
done under total intravenous anaesthesia, using injection of 
propofol and ketamine and maintaining spontaneous ventilation. 
This revealed a structure in the upper oesophagus, for which 
oesophageal dilatation was planned during the same 
anaesthesia. Subsequently the child was intubated with a 5.5 
mm cuffed endotracheal tube (ETT) using injection of atracurium 
0.5 mg/kg to prevent aspiration of blood. Intraoperatively 15 ml/
kg Ringer’s lactate was given to maintain hydration. Injection of 
ondansetron 0.1  mg/kg was given to prevent postoperative 
nausea and vomiting. The procedure lasted for 30 minutes. 
Subsequently the patient was reversed and extubated 
uneventfully.
Discussion
Rothmund–Thomson syndrome is a rare entity with wide 
variability in clinical expression. It was first described as an 
autosomal recessive skin condition by August von Rothmund in 
1868. Matthew Sydney Thomson further described it in 1936. The 
syndrome is named after both of them. The primary defect is in 
the RECQL4  helicase gene. The disease can involve multiple 
systems in the body.
Various manifestations reported include:4,5
•  Head, ENT, eye: microcephaly, juvenile cataracts, corneal 
dystrophy, saddle nose;
•  Dental abnormalities: microdontia, hypodontia, ectopic 
eruption, dental caries and prognathism;
•  Neuromuscular: may have mental retardation;
•  Orthopaedic: Proportionately short stature, may have small 
hands and feet, hypoplastic to absent thumbs, syndactyly, 
club foot;
•  Genitourinary/gastrointestinal: hypogonadism, cryptorchidism. 
Anteriorly placed anus or annular pancreas may be seen;
•  Others: skin changes including irregular erythema 
progressing to poikiloderma mainly in sun-exposed areas. 
Anhydrosis, hyperkeratotic lesions, dysplastic nails, anaemia.
Intravenous access may be difficult due to poikilodermatous skin 
changes. The airway may be difficult due to characteristic facies 
with frontal bossing, saddle nose and micrognathia. Airway 
manipulation can lead to intra-oral bleeding due to hypodontia 
and gum hypertrophy. Utmost care should be taken during 
placement of the laryngeal mask airway or intubation with ETT 
as the teeth may be loose. Also ETT tubes of smaller size should 
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be kept ready due to the structure of the oesophagus; a larger 
tube may interfere with oesophageal dilatation. In view of 
possible skin problems, careful padding of pressure points 
should be done and the BP cuff should be lined with soft cotton.
Infants and young children can have gastrointestinal disturbances 
including diarrhoea and vomiting, which makes them susceptible 
to dehydration, electrolyte disturbances and malnutrition. 
Serum electrolytes should therefore be monitored before 
elective surgery. Patients can also develop hypertension and 
nephropathy as complications. Adequate hydration must be 
ensured. Patients can develop hyperthermia due to hypohydrosis 
or anhydrosis.6 Thus, temperature monitoring becomes essential. 
Antibiotic coverage should be a priority as patients may be 
immunocompromised due to malnutrition. Short stature and 
bone deformities (abnormally formed, shortened or fused 
bones) can lead to difficulty in positioning. Anticholinergic drugs 
should be used cautiously as there may be an underlying 
glaucoma component. Also use of a drug such as suxamethonium, 
which raises intraocular pressure, should be weighed against the 
risk of a difficult airway. These procedures may be done in remote 
locations where all the necessary equipment to manage a 
difficult airway and experienced help may not be available. 
Haematological abnormalities ranging from anaemia and 
neutropenia to myelodysplasia may be present.6 Patients may 
require repeated anaesthesia exposure for multiple corrective 
surgeries, which can contribute to significant preoperative 
anxiety. A combination of pharmacological and non-
pharmacological measures should be used for anxiolysis.
Conclusion
RTS is a rare syndrome with multiple ramifications due to multi-
system involvement. Knowledge of the syndrome and its 
associated anomalies will help the anaesthetist to anticipate and 
plan the patient’s management for a better perioperative 
outcome.
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Figure 1:  Physical appearance of the patient.
